Chrysalyne D. Schmults

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Cutaneous squamous cell carcinoma: Estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012

Pritesh S. Karia, Jiali Han, Chrysalyne D. Schmults · Journal of the American Academy of Dermatology · 2013 · 835 citations

Medicine, Dermatology, Oncology +14

Factors Predictive of Recurrence and Death From Cutaneous Squamous Cell Carcinoma

Chrysalyne D. Schmults, Pritesh S. Karia, Joi B. Carter et al. · JAMA Dermatology · 2013 · 569 citations

Medicine, Oncology, Surgery +15

Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang et al. · The Lancet Oncology · 2020 · 480 citations · Full text

Medicine, Dermatology, Oncology +13

Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital Tumor Staging for Cutaneous Squamous Cell Carcinoma

Pritesh S. Karia, Anokhi Jambusaria‐Pahlajani, David P. Harrington et al. · Journal of Clinical Oncology · 2013 · 369 citations · Full text

Medicine, Oncology, Surgery +16